نتایج جستجو برای: biomarker validation

تعداد نتایج: 227799  

Many studies have investigated misregulation of miRNAs relevant to multiple sclerosis (MS) pathogenesis. Abnormal miRNAs can be used both as candidate biomarker for MS diagnosis and understanding the disease miRNA-mRNA regulatory network. In this comprehensive study, misregulated miRNAs related to MS were collected from existing literature, databases and via in silico prediction. A multi-staged...

Journal: :Clinical pharmacology and therapeutics 2015
J A Wagner J R Ball

The Institute of Medicine (IOM) released a groundbreaking 2010 report, Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease. Key recommendations included a harmonized scientific process and a general framework for biomarker evaluation with three interrelated steps: (1) Analytical validation -- is the biomarker measurement accurate? (2) Qualification -- is the biomarker associated...

Journal: :Journal of Molecular Biomarkers & Diagnosis 2013

Journal: :Journal of Proteomics & Bioinformatics 2017

Journal: :Molecular oncology 2007
Christian M Loch Arturo B Ramirez Yan Liu Cassandra L Sather Jeffrey J Delrow Nathalie Scholler Barbara M Garvik Nicole D Urban Martin W McIntosh Paul D Lampe

Perhaps the greatest barrier to translation of serum biomarker discoveries is the inability to evaluate putative biomarkers in high throughput validation studies. Here we report on the development, production, and implementation of a high-density antibody microarray used to evaluate large numbers of candidate ovarian cancer serum biomarkers. The platform was shown to be useful for evaluation of...

2012

In recent years, there has been a large increase in the use of both exploratory and validated biomarkers1, as they have been formally incorporated into the drug development process as indicators of the pharmacodynamic effect of drugs. a “biomarker” is a substance that is measured as an indicator of the normal biologic process, pathogenic process or pharmacologic response to a therapeutic interv...

2015
Brian B. Haab Ying Huang Seetharaman Balasenthil Katie Partyka Huiyuan Tang Michelle Anderson Peter Allen Aaron Sasson Herbert Zeh Karen Kaul Doron Kletter Shaokui Ge Marshall Bern Richard Kwon Ivan Blasutig Sudhir Srivastava Marsha L. Frazier Subrata Sen Michael A. Hollingsworth Jo Ann Rinaudo Ann M. Killary Randall E. Brand Zoltán Rakonczay

The validation of candidate biomarkers often is hampered by the lack of a reliable means of assessing and comparing performance. We present here a reference set of serum and plasma samples to facilitate the validation of biomarkers for resectable pancreatic cancer. The reference set includes a large cohort of stage I-II pancreatic cancer patients, recruited from 5 different institutions, and re...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید